查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1963658

大肠直肠癌筛检市场：全球产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

Colon Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 181 Pages | 商品交期: 2-5个工作天内

价格
简介目录

主要发现：

  • 大肠直肠癌筛检市场规模（2025年预测）：187亿美元
  • 预计市场规模（2032年）：244.5亿美元
  • 全球市场成长率（2025年至2032年复合年增长率）：3.9%

大肠直肠癌筛检市场研究范围：

大肠直肠癌筛检是指用于早期发现大肠直肠异常和大肠直肠癌（CRC）的诊断程序。大肠直肠癌是全球最常见且致死率最高的癌症之一。主要的筛检技术包括粪便检验，例如粪便免疫化学检查（FIT）和大便潜血试验（FOBT）；大肠镜检查；乙状结肠镜检查；以及胶囊内视镜检查。该市场涵盖内视镜、CT扫描仪、胶囊内视镜、检测套组和试剂等筛检产品，这些产品供应给医院、诊断和影像中心以及其他医疗机构。成长要素包括大肠直肠癌发病率的上升、意识提升的增强和预防措施的改进，以及诊断技术的进步。

市场成长因素：

全球大肠直肠癌筛检市场的主要驱动力是大肠直肠癌发生率的不断上升，这促使各国扩大筛检计画并加强早期检测工作。截至2020年，大肠直肠癌是全球第三大常见癌症，当年新增病例估计达190万例。据预测，到2040年，年新增病例数可能超过320万例。各国政府、医疗卫生系统和公共卫生机构之间的合作旨在提高筛检参与率、降低死亡率并减少长期治疗成本。对非侵入性筛检技术、远端医疗整合以及人工智慧辅助内视镜诊断的投资不断增加，也进一步推动了市场成长。

市场限制：

儘管市场前景广阔，但仍存在一些挑战。某些筛检方法，特别是粪便隐血大便潜血试验(FIT) 和粪便大便潜血试验试验 (FOBT) 等非侵入性检测，灵敏度有限，可能出现假阴性结果，尤其是在进行性腺瘤方面，因此需要进行后续大肠镜检查。这些限制可能会影响医疗专业人员对筛检方法的选择，并导致诊断延迟。区域监管的复杂性和报销政策的差异也可能影响不同族群的筛检普及率。

市场机会：

远端医疗和更广泛地提供居家检测工具，使早期筛检更加便捷易行，蕴藏着巨大的机会。包括Colosense和改良版ColoAlert在内的非侵入性粪便DNA和RNA检测，将扩大筛检范围，尤其是在那些不愿接受侵入性检查的人群中。免费发放筛检试剂盒和将人工智慧融入诊断等医疗保健倡议，有望促进市场渗透并提高患者依从性。

本报告解答的关键问题：

  • 推动全球大肠癌筛检市场成长的关键因素有哪些？
  • 医疗保健系统中应用最广泛的筛检类型和产品有哪些？
  • 科技进步如何改变大肠直肠癌筛检市场的竞争格局？
  • 全球大肠直肠癌筛检市场的主要参与者有哪些？他们正在采取哪些策略来维持其市场地位？
  • 全球大肠直肠癌筛检市场有哪些新兴趋势和未来前景？

目录

第一章执行摘要

第二章 市场概览

  • 市场范围和定义
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
  • 新冠疫情影响分析
  • 预测因子－相关性和影响

第三章 加值见解

  • 工具采纳分析
  • 监管状态
  • 价值链分析
  • PESTLE分析
  • 波特五力分析

第四章 定价分析，2024年

  • 主要亮点
  • 影响实施成本的关键因素
  • 按产品类型进行价格分析

第五章 全球大肠癌筛检市场展望

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模和年成长率
    • 绝对商机
  • 市场规模与销售量（单位）分析与预测
    • 2019-2024年市场规模绩效分析
    • 目前市场规模分析及预测（2025-2032年）
  • 全球大肠癌筛检市场展望（依筛检类型划分）
    • 引言/主要发现
    • 2019-2024年依筛检类型分類的市场规模、表现及销售量（单位）分析
    • 按筛检类型分類的当前市场规模和销售量（单位）分析及预测，2025-2032 年
      • 粪便检验
        • 粪便免疫化学检查（FIT）
        • 癒创木脂大便潜血试验（gFOBT）
        • 其他的
      • 大肠镜检查
      • 柔性乙状结肠镜检查
      • 胶囊内视镜
      • 其他的
    • 市场吸引力分析：筛检类型
  • 全球大肠癌筛检市场依产品类型展望
    • 引言/主要发现
    • 2019-2024年按产品类型分類的市场规模表现分析
    • 依产品类型分類的当前市场规模分析及预测（2025-2032年）
      • 内视镜检查
      • CT扫描仪
      • 胶囊内视镜
      • 检测套组和试剂
      • 其他的
    • 按产品类型分類的市场吸引力分析
  • 全球大肠直肠癌筛检市场展望：终端用户
    • 引言/主要发现
    • 按最终用户分類的市场规模绩效分析，2019-2024 年
    • 按最终用户分類的当前市场规模分析及预测（2025-2032 年）
      • 医院
      • 诊断和影像中心
      • 研究和学术机构
      • 其他的
    • 最终用户市场吸引力分析

第六章 全球大肠直肠癌筛检市场区域展望

  • 主要亮点
  • 2019年至2024年各地区市场规模表现及销售量（单位）分析
  • 按地区分類的当前市场规模和销售量（单位）分析与预测（2025-2032 年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分類的市场吸引力分析

第七章 北美大肠癌筛检市场展望

第八章 欧洲大肠癌筛检市场展望

第九章 东亚大肠癌筛检市场展望

第十章 南亚和大洋洲结直肠癌筛检市场展望

第十一章：拉丁美洲大肠癌筛检市场展望

第十二章 中东和非洲大肠癌筛检市场展望

第十三章 竞争格局

  • 2024年市占率分析
  • 市场结构
    • 市场竞争格局分析
    • 竞争对手仪錶板
  • 公司简介（详情 - 概述、财务状况、策略、近期发展）
    • Olympus Corporation
    • PENTAX Medical（Hoya Corporation）
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Ambu A/S
    • Baxter（Hillrom &Welch Allyn）
    • EndoFresh
    • Bracco SpA
    • Varay Laborix
    • QuidelOrtho Corporation
    • Novigenix SA
    • Guardant Health, Inc.
    • Mainz Biomed NV
    • Eiken Chemical Co., Ltd.

第十四章附录

简介目录
Product Code: PMRREP35162

Persistence Market Research has recently released a comprehensive report on the colon screening market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global colon screening market from 2025 to 2032.

Key Insights:

  • Colon Screening Market Size (2025E): USD 18.7 Billion
  • Projected Market Value (2032F): USD 24.45 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Colon Screening Market - Report Scope:

Colon screening involves diagnostic methods used for early detection of colorectal abnormalities and colorectal cancer (CRC), which is among the most common and fatal cancers worldwide. Major screening techniques include stool-based tests such as fecal immunochemical tests (FIT) and fecal occult blood tests (FOBT), colonoscopy, flexible sigmoidoscopy, capsule endoscopy, and others. The market covers screening products such as endoscopes, CT scanners, capsule endoscopes, and test kits & reagents, catering to hospitals, diagnostic & imaging centers, and other healthcare facilities. Growth is driven by rising CRC incidence, increasing awareness and preventive initiatives, and advancements in diagnostic technologies.

Market Growth Drivers:

The global colon screening market is primarily driven by the growing incidence of colorectal cancer, prompting expansion of national screening programs and early detection efforts. CRC was the third most common cancer globally in 2020, with an estimated 1.9 million new cases that year, and projections indicate cases may exceed 3.2 million annually by 2040. Alliances between governments, healthcare systems, and public health agencies aim to increase screening participation, reducing mortality and long-term treatment costs. Growing investments in non-invasive screening technologies, telemedicine integration, and AI-assisted endoscopic diagnostics further bolster market growth.

Market Restraints:

Despite the market's growth prospects, certain challenges exist. Sensitivity limitations of some screening methods, especially non-invasive tests such as FIT and FOBT, can lead to false negatives, particularly for advanced adenomas, necessitating follow-up colonoscopy tests. Such limitations may affect healthcare professionals' screening choices or result in delayed diagnosis. Regulatory complexities and variations in reimbursement policies across regions may also impact adoption rates among different population segments.

Market Opportunities:

Significant opportunities lie in expanding access to telemedicine and at-home testing tools, making early screening more convenient and accessible. Non-invasive stool DNA and RNA-based tests, including emerging products like Colosense and enhanced ColoAlert, expand screening reach, particularly among individuals reluctant to undergo invasive procedures. Healthcare initiatives distributing free screening kits and integrating AI into diagnostics are expected to enhance market penetration and patient compliance.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the colon screening market globally?
  • Which screening types and products are most widely adopted across healthcare systems?
  • How are technological advancements reshaping the competitive landscape of the colon screening market?
  • Who are the key players in the global colon screening market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global colon screening market?

Competitive Intelligence and Business Strategy:

Leading players in the colon screening market focus on enhancing diagnostic accuracy, expanding product offerings, and forging strategic collaborations to strengthen market presence. Companies leverage advanced imaging tools, AI-enabled endoscopy platforms, and telehealth solutions to improve early detection rates and patient outcomes. Partnerships with healthcare providers, government screening initiatives, and technology developers facilitate broader adoption of innovative screening solutions. Continuous R&D investments and new product launches are essential for sustaining competitive advantage.

Key Companies Profiled:

  • Olympus Corporation
  • PENTAX Medical (Hoya Corporation)
  • FUJIFILM Holdings Corporation
  • Medtronic
  • Ambu A/S
  • Baxter (Hillrom & Welch Allyn)
  • EndoFresh
  • Bracco
  • Varay Laborix
  • Guardant Health, Inc.
  • Novigenix SA
  • Eiken Chemical Co., Ltd.
  • Mainz Biomed N.V.

Colon Screening Market Research Segmentation:

By Screening Type

  • Stool-Based Tests
  • Fecal Immunochemical Test (FIT)
  • Guaiac-Based Fecal Occult Blood Test (gFOBT)
  • Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy
  • Others

By Product Type

  • Endoscopes
  • CT Scanners
  • Capsule Endoscopes
  • Test Kits & Reagents
  • Others

By End-user

  • Hospitals
  • Diagnostic & Imaging Centers
  • Research & Academic Institutions
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Colon Screening Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-economic Factors
    • 2.3.1. Global Sectoral Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Tool Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Deployment Costs
  • 4.3. Pricing Analysis, By Product Type

5. Global Colon Screening Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Colon Screening Market Outlook: Screening Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Screening Type, 2019 - 2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
      • 5.3.3.1. Stool-based Tests
        • 5.3.3.1.1. Fecal Immunochemical Test (FIT)
        • 5.3.3.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
        • 5.3.3.1.3. Others
      • 5.3.3.2. Colonoscopy
      • 5.3.3.3. Flexible Sigmoidoscopy
      • 5.3.3.4. Capsule Endoscopy
      • 5.3.3.5. Others
    • 5.3.4. Market Attractiveness Analysis: Screening Type
  • 5.4. Global Colon Screening Market Outlook: Product Type
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2024
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 5.4.3.1. Endoscopes
      • 5.4.3.2. CT Scanners
      • 5.4.3.3. Capsule Endoscopes
      • 5.4.3.4. Test Kits & Reagents
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Product Type
  • 5.5. Global Colon Screening Market Outlook: End-user
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019 - 2024
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Diagnostic & Imaging Centers
      • 5.5.3.3. Research & Academic Institutions
      • 5.5.3.4. Others
    • 5.5.4. Market Attractiveness Analysis: End-user

6. Global Colon Screening Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Colon Screening Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Screening Type
    • 7.2.3. By Product Type
    • 7.2.4. By End-user
    • 7.2.5. By Application
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 7.4.1. Stool-based Tests
      • 7.4.1.1. Fecal Immunochemical Test (FIT)
      • 7.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 7.4.1.3. Others
    • 7.4.2. Colonoscopy
    • 7.4.3. Flexible Sigmoidoscopy
    • 7.4.4. Capsule Endoscopy
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.5.1. Endoscopes
    • 7.5.2. CT Scanners
    • 7.5.3. Capsule Endoscopes
    • 7.5.4. Test Kits & Reagents
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic & Imaging Centers
    • 7.6.3. Research & Academic Institutions
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Colon Screening Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Screening Type
    • 8.2.3. By Product Type
    • 8.2.4. By End-user
    • 8.2.5. By Application
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 8.4.1. Stool-based Tests
      • 8.4.1.1. Fecal Immunochemical Test (FIT)
      • 8.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 8.4.1.3. Others
    • 8.4.2. Colonoscopy
    • 8.4.3. Flexible Sigmoidoscopy
    • 8.4.4. Capsule Endoscopy
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.5.1. Endoscopes
    • 8.5.2. CT Scanners
    • 8.5.3. Capsule Endoscopes
    • 8.5.4. Test Kits & Reagents
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic & Imaging Centers
    • 8.6.3. Research & Academic Institutions
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Colon Screening Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Screening Type
    • 9.2.3. By Product Type
    • 9.2.4. By End-user
    • 9.2.5. By Application
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 9.4.1. Stool-based Tests
      • 9.4.1.1. Fecal Immunochemical Test (FIT)
      • 9.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 9.4.1.3. Others
    • 9.4.2. Colonoscopy
    • 9.4.3. Flexible Sigmoidoscopy
    • 9.4.4. Capsule Endoscopy
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.5.1. Endoscopes
    • 9.5.2. CT Scanners
    • 9.5.3. Capsule Endoscopes
    • 9.5.4. Test Kits & Reagents
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic & Imaging Centers
    • 9.6.3. Research & Academic Institutions
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Colon Screening Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Screening Type
    • 10.2.3. By Product Type
    • 10.2.4. By End-user
    • 10.2.5. By Application
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 10.4.1. Stool-based Tests
      • 10.4.1.1. Fecal Immunochemical Test (FIT)
      • 10.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 10.4.1.3. Others
    • 10.4.2. Colonoscopy
    • 10.4.3. Flexible Sigmoidoscopy
    • 10.4.4. Capsule Endoscopy
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.5.1. Endoscopes
    • 10.5.2. CT Scanners
    • 10.5.3. Capsule Endoscopes
    • 10.5.4. Test Kits & Reagents
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic & Imaging Centers
    • 10.6.3. Research & Academic Institutions
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Colon Screening Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Screening Type
    • 11.2.3. By Product Type
    • 11.2.4. By End-user
    • 11.2.5. By Application
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 11.4.1. Stool-based Tests
      • 11.4.1.1. Fecal Immunochemical Test (FIT)
      • 11.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 11.4.1.3. Others
    • 11.4.2. Colonoscopy
    • 11.4.3. Flexible Sigmoidoscopy
    • 11.4.4. Capsule Endoscopy
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.5.1. Endoscopes
    • 11.5.2. CT Scanners
    • 11.5.3. Capsule Endoscopes
    • 11.5.4. Test Kits & Reagents
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic & Imaging Centers
    • 11.6.3. Research & Academic Institutions
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Colon Screening Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Screening Type
    • 12.2.3. By Product Type
    • 12.2.4. By End-user
    • 12.2.5. By Application
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 12.4.1. Stool-based Tests
      • 12.4.1.1. Fecal Immunochemical Test (FIT)
      • 12.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 12.4.1.3. Others
    • 12.4.2. Colonoscopy
    • 12.4.3. Flexible Sigmoidoscopy
    • 12.4.4. Capsule Endoscopy
    • 12.4.5. Others
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 12.5.1. Endoscopes
    • 12.5.2. CT Scanners
    • 12.5.3. Capsule Endoscopes
    • 12.5.4. Test Kits & Reagents
    • 12.5.5. Others
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic & Imaging Centers
    • 12.6.3. Research & Academic Institutions
    • 12.6.4. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Olympus Corporation
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Deployments
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. PENTAX Medical (Hoya Corporation)
    • 13.3.3. FUJIFILM Holdings Corporation
    • 13.3.4. Medtronic
    • 13.3.5. Ambu A/S
    • 13.3.6. Baxter (Hillrom & Welch Allyn)
    • 13.3.7. EndoFresh
    • 13.3.8. Bracco S.p.A.
    • 13.3.9. Varay Laborix
    • 13.3.10. QuidelOrtho Corporation
    • 13.3.11. Novigenix SA
    • 13.3.12. Guardant Health, Inc.
    • 13.3.13. Mainz Biomed N.V.
    • 13.3.14. Eiken Chemical Co., Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations